Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

PRIMO 2025 | AI in cancer research: advancing clinical trials & real-world data analysis

Merrick Ross • 7 Feb 2025
PRIMO 2025
General

Merrick Ross, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, comments on the potential benefits of artificial intelligence in cancer research, highlighting its potential to aid in designing clinical trials and analyzing real-world data to inform decision-making. Dr Ross notes that the past decade has seen significant advancements, and he anticipates even more remarkable progress in the next decade. This interview took place at the PRIMO 2025 congress in Honolulu, HI.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Merrick Ross

mRNA vaccines in melanoma: targeting neoantigens to enhance immunotherapy & reduce toxicity
4:37
mRNA vaccines in melanoma: targeting neoantigens to enhance immunotherapy & reduce toxicity
Merrick Ross • 7 Feb 2025
Optimizing immunotherapy: predictive biomarkers, resistance strategies & personalized medicine
3:37
Optimizing immunotherapy: predictive biomarkers, resistance strategies & personalized medicine
Merrick Ross • 7 Feb 2025
Predictive biomarkers & neoadjuvant platforms in cancer treatment personalization
3:33
Predictive biomarkers & neoadjuvant platforms in cancer treatment personalization
Merrick Ross • 7 Feb 2025
Anti-LAG-3 and anti-PD-1 combination shows promising results in advanced melanoma treatment
1:07
Anti-LAG-3 and anti-PD-1 combination shows promising results in advanced melanoma treatment
Merrick Ross • 7 Feb 2025

Related Videos

What are the key determinants of cancer-related cognitive impairment?
3:25
What are the key determinants of cancer-related cognitive impairment?
Filippos Koinis • 1 Jun 2026
Management of cancer-related cognitive impairment in patients
2:44
Management of cancer-related cognitive impairment in patients
Filippos Koinis • 1 Jun 2026
Gender representation in Phase III solid tumor trials at ASCO 2015-2025
1:24
Gender representation in Phase III solid tumor trials at ASCO 2015-2025
Sarbajit Mukherjee • 1 Jun 2026
Quality gaps in online patient information about AI in cancer care
1:24
Quality gaps in online patient information about AI in cancer care
Eleonora Teplinsky • 31 May 2026
The content of VJOncology is intended for healthcare professionals